Briacell Therapeutics Corp. Common Shares BCTX
Key Stats
- Today's Range
- $3.43 – $3.67
- 50-Day Range
- $2.60 – $4.00
- 52-Week Range
- $2.60 – $30.00
- Volume
- 209K shs
- Average Volume
- 149K shs
- Market Cap
- $30.45 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 1.30
- Price / Sales
- —
Short Interest
- Short Interest
- 0.29%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- —
- Net Income
- $-30,976,383
- Net Margin
- —
- Return on Equity
- -132.33%
- Debt-to-Equity
- —
About Briacell Therapeutics Corp. Common Shares
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
Related Stocks
Compare head-to-head: BCTX vs LLY·BCTX vs JNJ·BCTX vs ABBV·BCTX vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.